BiotechTube
Home/MitoSense/Xian Peng Jiang
XP

Xian Peng Jiang

Chief Scientific Officer

MitoSense

Therapeutic Areas

Neurodegenerative Diseases

MitoSense Pipeline

DrugIndicationPhase
MOT™ for ALSAmyotrophic Lateral Sclerosis (ALS)Pre-clinical
MOT™ PlatformAlzheimer's Disease, Parkinson's Disease, Huntington's Disease, Multiple SclerosisResearch/Discovery

Leadership Team at MitoSense

BS
Brent Segal, PhD
Chief Executive Officer
VH
Van Hipp
Chairman
CB
Catherine Baucom, MD, PhD
Chief Medical Officer
RW
Rick Waldo
Board Member
View full MitoSense profile